This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Uterine Cervical Neoplasms
and you are
over 18
years old
The phase for this study is not defined.
Show me locations

The purpose

To detect differences in MR spectroscopy, diffusion weighted MR, diffusion tensor imaging (DTI) or dynamic contrast enhancement (DCE) MR imaging between primary cervical tumors and normal cervical tissue.

Provided treatments

  • Device: MR Spectroscopy
  • Device: Fat-Saturation and Diffusion-Weighted Imaging
  • Device: Dynamic Contrast Enhancement MRI (MR-DCE)
  • Device: Diffusion Tensor Imaging (DTI)

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01060033. The sponsor of the trial is Washington University School of Medicine and it is looking for 9 volunteers for the current phase.
Official trial title:
A Study of Novel Magnetic Resonance Imaging Sequences for Target Delineation and Prognostication in Cervical Cancer